All questions

Visits and checks

Which offers call for a pause?

Pause at a claim you cannot check. Ask for the record behind it before adding your payment details.

Claims of approval based on a badge

As of September 2026, the FDA says facility registration and a drug code do not establish product approval.

Under the FDA’s guidance checked that month, it is false to call a compounded medicine FDA-approved.

Ask for the actual product record and the full ingredient name.

Products labelled for lab research but sold for people

A “research use only” label says a product is for lab research rather than treating a patient.

In warning letters reviewed in September 2026, the FDA said some sellers were offering such products for people to use. It judged what the products were being sold for from the advertising, despite the research labels.

Those letters state the FDA’s allegations to particular businesses; they are not court findings.

That label does not answer whether the product can be supplied as medicine. Ask who would assess you, which pharmacy would make it and what legal condition would allow that ingredient.

A promise that skips the evidence

The published ipamorelin studies in people found by October 1, 2026, did not test muscle gain, fat loss, sleep or ageing.

Ask whether the cited study was in people and used the proposed product. Keep animal results labelled as animal results.

A name you cannot verify

Health websites can display fake seals and logos that look official, warns the Federal Trade Commission.

Get the full name of your treating professional, such as a doctor, together with the pharmacy’s full name. Check both names in your state’s licence records.

At the end of this chapter

Evidence notes

Ipamorelin record checked as of October 1, 2026.

Care-access notes checked as of September 2026.